A Randomized Trial Comparing Same Day Discharge and a Single Bolus of Abciximab to Overnight Hospitalization and Bolus + Perfusion Abciximab After Uncomplicated Trans-Radial Coronary Artery Stenting.

Trial Profile

A Randomized Trial Comparing Same Day Discharge and a Single Bolus of Abciximab to Overnight Hospitalization and Bolus + Perfusion Abciximab After Uncomplicated Trans-Radial Coronary Artery Stenting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2008

At a glance

  • Drugs Abciximab (Primary)
  • Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Coronary disorders; Coronary stent thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms EASY
  • Most Recent Events

    • 10 Nov 2008 Results of a cost-minimisation analysis of the EASY trial presented at the 81st Scientific Sessions of the American Heart Association (AHA), 2008.
    • 13 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top